BriaCell Therapeutics Intends To Offer To Sell Common Shares And Warrants In Public Offering; No Terms Disclosed
BriaCell Therapeutics Intends To Offer To Sell Common Shares And Warrants In Public Offering; No Terms Disclosed
BriaCell Therapeutics打算公开发行普通股和Warrants; 没有透露条款
All of the common shares and warrants are to be sold by the Company. The Company intends to use the net proceeds from the offering primarily for working capital requirements, general corporate purposes, and the advancement of business objectives.
所有普通股和认股权证将由公司出售。公司打算将本次发行的净收益主要用于营运资金需求、一般公司用途和推进业务目标。
资讯热榜
更新时间